Abstract Microarray gene expression experiments often consider specific developmental stages, tissue sources, or reproductive technologies. This focus hinders the understanding of the cattle embryo transcriptome. To address this, four microarray experiments encompassing three developmental stages (7, 25, 280 days), two tissue sources (embryonic or extra-embryonic), and two reproductive technologies (artificial insemination or AI and somatic cell nuclear transfer or NT) were combined using two sets of meta-analyses. The first set of meta-analyses uncovered 434 genes differentially expressed between AI and NT (regardless of stage or source) that were not detected by the individual-experiment analyses. The molecular function of transferase activity was enriched among these genes that included ECE2, SLC22A1, and a gene similar to CAMK2D. Gene POLG2 was over-expressed in AI versus NT 7-day embryos and was under-expressed in AI versus NT 25-day embryos. Gene HAND2 was overexpressed in AI versus NT extra-embryonic samples at 280 days yet under-expressed in AI versus NT embryonic samples at 7 days. The second set of meta-analyses uncovered enrichment of system, organ, and anatomical structure development among the genes differentially expressed between 7-and 25-day embryos from either reproductive technology. Genes PRDX1and SLC16A1 were over-expressed in 7-versus 25-day AI embryos and underexpressed in 7-versus 25-day NT embryos. Changes in stage were associated with high number of differentially expressed genes, followed by technology and source. Genes with Funct Integr Genomics (2011) 11:139-150 DOI 10.1007 transferase activity may hold a clue to the differences in efficiency between reproductive technologies.
Introduction
Hundreds of genes influence embryo development in human and reproduction models (Beyhan et al. 2007; Humpherys et al. 2002; Kues et al. 2008) . The cattle embryo is a well-established reproductive model to study gene expression changes in embryonic and maternal tissues. Microarray gene expression experiments have profiled the expression of thousands of genes across conditions such as tissue sources (embryonic or extra-embryonic), developmental stages, and reproductive technologies used to create the cattle embryo (Huang et al. 2010; Pfister-Genskow et al. 2005; Smith et al. 2009; Somers et al. 2006) . The detection of genes that are differentially expressed between the embryo and maternal components or at different stages is useful in understanding embryo survival and healthy development. Likewise, the detection of differential gene expression between reproductive technologies within and across developmental stages and tissue sources sheds insights into the lower efficiency of somatic cell nuclear transfer (NT) to produce healthy calves relative to artificial insemination (AI), the standard reproductive technique in cattle (Dinnyes et al. 2008; Everts et al. 2008; Khatib et al. 2009; Marjani et al. 2009 ).
The identification and understanding of genes and gene pathways that are critical for embryo development have been hindered by the limited size and focus of most experiments on a particular tissue source (Everts et al. 2008) , developmental stage (Smith et al. 2005) , or reproductive technology (Thelie et al. 2009) . Two examples of this situation are the relative expression level of (1) genes that have transferase activity function between reproductive technologies and (2) genes that are part of system development processes between developmental stages. With respect to the former case, multiple studies have reported a difference in the expression of genes that have transferase activity function between normal and abnormal pregnancies at particular stages of mammalian development or tissue sources (Prokopenko et al. 2002; El-Bassiouni et al. 2005; Toledo et al. 2006; Rausell et al. 2007; Obolenskaya et al. 2010 ). However, no study has looked at the differences across stages or tissue sources. With respect to the latter case, several studies have reported differences in genes that are part of the system development process (Ruberte et al. 1993; Cardoso and Lu 2006; Laranjeira and Pachnis 2009 ). However, no study has compared the patterns across reproductive technologies. The goal of this study was to obtain a more comprehensive understanding of genes, molecular functions, and biological processes associated with cattle embryo development and viability. To accomplish this, the information from four cattle microarray experiments was integrated using two sets of meta-analyses that provided complementary understanding Rodriguez-Zas et al. 2008) . The first set of meta-analyses offered broad insights into the differential gene expression between AI and NT technologies regardless of developmental stage or tissue source. This analysis allowed the profiling of genes with transferase activity between reproductive technologies across all developmental stages and tissue sources considered. The second set of meta-analyses provided detailed knowledge into the differential gene expression between developmental stages or tissue sources within technology under particular conditions. This analysis allowed the profiling of genes belonging to the system development process between developmental stages in both reproductive technologies considered. The genes identified by the meta-analyses and subsequent gene ontology analysis allowed the characterization of general and condition-specific expression profiles, functions, and processes.
Materials and methods
Data sets Four cattle microarray experiments that compared gene expression between reproductive technologies using different developmental stages and tissue sources were integrated. The common comparison between AI and NT studied in all these experiments, the shared platform, and the availability of the cattle genome facilitated the combination of information from these experiments using meta-analysis and subsequent detection of genes associated with embryo development and interpretation of results. The experiments encompassed AI and NT samples from one of two tissue sources (embryonic or E and extra-embryonic or X) and one of three developmental stages (day 7 of gestation or d7, day 25 of gestation or d25, and at term or d280). Based on the stage and source studied, the four experiments are denoted d280X (Everts et al. 2008) , d7E (Marjani et al. 2009; Smith et al. 2008) , d25X (Everts et al. 2007a) , and d25E (Everts et al. 2007b ). The number of AI (and NT) samples were nine (20), five (six), six (six), and nine (20) for d7E, d25E, d25X, and d280X, respectively. In the d7E study, NT embryos from two cell lines were analyzed as one NT group based on preliminary comparisons that indicated consistent profiles. The microarray platform included 13,257 spotted oligonucleotide (Gene Expression Omnibus platform identifier GPL2853) created from cattle placenta and spleen cDNA libraries. Of the probes, 9,655 have a match on human RefSeq, 1,460 have identification on cattle UniGene, 54 have no hits, and the remainder matched other mouse, human, or cattle databases (Loor et al. 2007 ). All studies used a reference design with dye swap, and each sample appeared in two microarrays.
Data processing and normalization were performed as described by Rodriguez-Zas et al. (2006) and Adams et al. (2008) and implemented in Beehive (http://stagbeetle. animal.uiuc.edu/Beehive). Briefly, spots flagged by the scanning software (GenePix Pro 5.0) or that did not surpass the median intensity of the negative control spots were removed and the background-subtracted foreground intensities were log2-transformed. A global LOWESS normalization was used, duplicate spots were averaged, and global dye and microarray effects were removed. All data processing and analyses were conducted using the SAS mixed procedure (SAS Institute Inc., NC, USA). The total number of observations analyzed per study was 29, 11, 12, and 29 for d7E, d25E, d25X, and d280X, respectively. Following normalization, two sets of analyses were used to gain a thorough understanding of the cattle embryo transcriptome.
First set of meta-analyses to identify differentially expressed genes between AI and NT across developmental stages and tissue sources Three approaches to combine information across all experiments and identify differentially expressed genes between AI and NT were considered. A detailed description of the complementary properties of these approaches is provided in Rodriguez-Zas et al. (2008) and Adams et al. (2008) . In the first approach, the data from each experiment were analyzed separately (individualexperiment analyses). Lists of differentially expressed genes from each experiment were obtained, and the genes that overlap two or more lists were identified. In the individual-experiment analyses, each gene was described with a linear mixed-effects model that included the fixed effects of dye, reproductive technique, and the random effects of sample and microarray. Numerous genes were differentially expressed between term and preterm calving samples in experiment d280X (Everts et al. 2007a) , and thus this factor was included as fixed effect in the model for this experiment. Second, a study-level meta-analysis (study) that combines estimates of differential expression between AI and NT resulting from the individual-experiment analyses was undertaken . The estimates were standardized by their standard errors to account for differences in the precision between experiments. The linear mixedeffects model used to analyze the standardized estimates of differential expression included an overall mean and the random effect of experiment assuming heterogeneity of variances across experiments and zero co-variance between experiments. Third, a sample-level meta-analysis (sample) was used to combine the normalized gene expression intensities across all four experiments. A linear mixedeffects model that included the fixed effects of dye, reproductive technology, and experiment and the random effects of sample and microarray was used to describe the expression of each gene. The effect of amplification on the d7E samples was not significant and was removed from the model (Smith et al. 2005) .
Second set of meta-analyses to identify differentially expressed genes between developmental stages and tissue sources within reproductive technology An alternative specification of the sample-level meta-analysis was used to gain complementary information to that resulting from the first set of meta-analysis. Benjamini and Hochberg 1995) and fold change of >1.23 were considered differentially expressed. Four scenarios were investigated using funnel plots: (a) genes that were not differentially expressed in any individual experiment and were detected by the study-level and sample-level meta-analyses, (b) genes that had differential expression between AI and NT samples in two experiments and were not detected by meta-analysis, (c) genes that were found differentially expressed in the sample-level meta-analysis and were not in the study-level meta-analysis, and (d) genes that were differentially expressed in the study-level meta-analysis and were not in the sample-level meta-analysis. Gene set enrichment analysis (Al-Shahrour et al. 2006 ) was undertaken to uncover overrepresented gene ontology (GO, The Gene Ontology Consortium 2000) biological processes, molecular functions, and KEGG pathways (Kanehisa and Goto 2000) using the standardized estimates of differential expression between the conditions (e.g., AI vs NT, 7 vs 25 days). Among all the genes analyzed, 31.6% were homologous to human genes that have GO annotations.
Results
Genes differentially expressed between AI and NT across developmental stages and tissue sources identified from the first set of meta-analyses
The number of differentially expressed genes between AI and NT identified from the individual-experiment analyses ranged from 36 to 846 (Table 1) . Supplementary Materials Table 1 presents the gene identifier, estimate of difference in expression between conditions and P value from all the individual-experiment analyses. No particular sign or pattern of differential expression dominated across the individual-experiment analyses, with the exception of experiment d280X that had 189 and 657 positively and negatively differentially expressed genes, respectively. The percentage of genes differentially expressed and overlapping among individual-experiment analyses ranged from 0% to 13.1% (average of 7.65%) relative to the number of genes identified in one of the experiments. The study-level and sample-level meta-analyses uncovered 168 and 380 differentially expressed genes between AI and NT across experiments, respectively (Table 1) . Supplementary Materials Table 2 presents the gene identifier, estimate of difference in expression between conditions and P value resulting from the study-level and sample-level metaanalyses. The Venn diagram in Fig. 1 depicts the overlap of differentially expressed genes from the individualexperiment analyses and the study-level and sample-level meta-analyses. A total of 434 differentially expressed genes detected by the sample-level and study-level meta-analysis were not detected by the individual-experiment analyses. Two genes were differentially expressed between AI and NT in all three types of analyses. The number of genes differentially expressed in one, two, and more individualexperiment analyses simultaneously was 1,028, 14, and 0, respectively. Eight of the fourteen genes differentially expressed in two experiments had opposite signs ( Table 2) . Of the 380 and 168 genes differentially expressed between AI and NT detected by the sample and study-level metaanalyses, respectively, 376 and 168 genes were not detected in the overlap of two individual-experiment analyses. All (17) or most (81 out of 87) genes that were differentially expressed between AI and NT in the study-and sample-level meta-analysis, respectively, had consistent sign with the individual-experiment analyses. From the GO analysis of the results from the meta-analyses, the molecular function transferase activity (GO:0016772, P value<0.0008) was d280X day 280 extra-embryonic samples, d7E day 7 embryos, d25X day 25 extra-embryonic sample, d25E day 25 embryos a Number of differentially expressed genes between AI and NT (P value<1×10 −3 , fold change >1.23) within individual-experiment analyses and studylevel standardized (study) and sample-level (sample) meta-analysis (diagonals). "+" denotes over-expression in AI relative to NT and "−" denotes underexpression in AI relative to NT b Upper off-diagonals are the number of genes identified differentially expressed in all pairs of analyses relative to the maximum number of significant genes that can overlap in both analyses c Lower off-diagonals are the percentage of genes identified differentially expressed in all pairs of analyses relative to the maximum number of significant genes that can overlap in both analyses.
over-represented among the genes detected by the samplelevel meta-analysis. Funnel plots were used to compare the results from the individual-experiment, study-level, and sample-level metaanalyses. Figure 2 presents the estimates (or log2-fold change between AI and NT and 95% confidence intervals) of four gene expression scenarios of relevance. The estimate from the study-level meta-analysis appeared distant from the rest because this value was standardized.
Genes differentially expressed between developmental stages and tissue sources within reproductive technology identified by the second set of meta-analyses Six contrasts of gene expression between developmental stages and tissue sources within reproductive technology (either AI or NT) were investigated among the second set of meta-analyses (Table 3 ). The first four contrasts compared the expression of genes between developmental stages within reproductive technology and tissue source. The last two contrasts compared the expression of genes between tissue sources within reproductive technology and developmental stage. The contrasts (and number of differentially expressed genes) were (1) 7 versus 25 days in AI embryos (483 genes), (2) 7 versus 25 days in NT embryos (1,149 genes), (3) 25 versus 280 days in AI extraembryonic tissue (340 genes), (4) 25 versus 280 days in NT extra-embryonic samples (334 genes), (5) embryonic versus extra-embryonic AI samples at 25 days (82 genes), and (6) embryonic versus extra-embryonic NT samples at 25 days (11 genes). Supplementary Materials Tables 3 and 4 present the gene identifier and estimate of difference in expression between conditions and P value for the first four contrasts and last two contrasts, respectively.
The overlap of genes differentially expressed between 7-and 25-day samples, separate for AI (483 genes) and NT (1,149 genes), resulted in 373 genes (372 with GO annotations). Numerous biological processes relevant to embryo development were over-represented among the genes with over-expression at 7 days relative to 25 days, including anatomical structure development (P value<7× 10 −5 ), multicellular organismal development (P value<3× 10 −4 ), system development (P value<7×10 −5 ), and organ development (P value<2×10 −4 ).
Several summaries can be drawn from the number of differentially expressed genes detected by the second set of meta-analyses. First, developmental stage (7 versus 25 days) was associated with a high number of differentially expressed genes in NT embryos (1,149 genes), distantly followed by AI embryos (483 genes). Second, tissue source (embryonic versus extra-embryonic) was associated with a low number of differentially expressed genes in AI at 25 days (82 genes) and even lower numbers in NT at 25 days (11 genes). Third, the number of genes differentially expressed between 25 and 280 days in extraembryonic sources was similar in AI and NT samples (340 and 334 genes, respectively). d280X 280-day extra-embryonic samples, d7E 7-day embryos, d25X 25-day extra-embryonic samples, d25E 25-day embryos Fig. 1 Venn diagram of the number of differentially expressed genes detected by one or more individual-experiment analyses (Ind), the study-level meta-analysis (Study), and the sample-level (Sample) meta-analysis
Discussion
Genes differentially expressed between AI and NT across developmental stages and tissue sources identified by the first set of meta-analyses
The trends on the number of genes differentially expressed between AI and NT detected by the individual-experiment analyses are consistent with previous reports from each experiment (Everts et al. 2008; Everts et al. 2007a, b; Marjani et al. 2009; Smith et al. 2008) . The low overlap among the lists of genes from individual-experiment analyses may be due to the limited precision of analyses and demonstrates the potential limitation of simple comparison of lists of genes from individual-experiment analysis to combine experiments (Table 1 ). The pooling of consistent differential expression between AI and NT attained by the study-and sample-level meta-analyses allowed the detection of 434 differentially expressed genes that were not detected by the individual-experiment analyses (Fig. 1) . The number of genes differentially expressed between AI and NT detected in the first set of meta-analyses is low relative to the total number of genes analyzed. This result suggests that the lower reproductive efficiency and higher incidence of large-offspring syndrome in NT may be associated with significant differences in the expression of a few genes and less significant differences in the expression of the remainder genes. The detection of functional categories and individual genes that exhibit consistent differential expression between Fig. 2 Funnel plots of differential expression estimates (square) and 95% confidence interval limits (horizontal line) for genes deoxycytidylate deaminase (DCTD), mitochondrial fission regulator 1 (MTFR1), vesicle-associated membrane protein 3 (VAMP3), and structural maintenance of chromosomes 4-like 1 (SMC4L1), by individual-experiment, study-level (study), and sample-level (sample) meta-analyses. STU denotes study-level meta-analysis of standardized estimates, SAM denotes sample-level meta-analysis, and the individual-experiment analyses are denoted: d25X (25-day extra-embryonic samples), d25E (25-day embryonic samples), d280X (280-day extra-embryonic sample), and d7E (7-day embryo samples). The size of the square denoting the estimate corresponds to the number of observations in the experiment (d25X n=12; d25E n=11; d280X n=29; d7E n=29; STU n=4; SAM n=89). Analyses detecting significant (P value <1×10 −3 , fold change >1.23) differential expression between AI and NT samples are denoted by an asterisk AI and NT across developmental stages and tissue sources offers insights into the systematic impact of the technologies on the transcriptome and ultimately on reproductive efficiency. The GO molecular function transferase activity was enriched among the differentially expressed genes detected by the sample-level meta-analysis. The importance of this function on embryo development stems from the role of transferase enzymes catalyzing the transfer of a chemical group or radical from one molecule to another.
Genes that exhibit transferase activity and were detected in this study are discussed. Gene v-akt murine thymoma viral oncogene homolog 1 (AKT1, AY781100, OLIGO_07021) was over-expressed in AI relative to NT samples. This gene is important in placental development and fetal growth, and deficiencies in expression can lead to restricted development and growth (Yang et al. 2003) . Likewise, activin A receptor, type IIA (ACVR2A, BF039418, OLIGO_04559), was overexpressed in AI versus NT samples and is suggested to have multiple roles in murine organogenesis (Feijen et al. 1994) . Endothelin converting enzyme 2 (ECE2, AF489575, OLIGO_01033) was over-expressed in NT relative to AI samples. This gene is known to act in human brain and heart development, along with other processes crucial to human embryonic development (Yanagisawa et al. 2000) . Lastly, gene polymerase (DNA-directed), gamma 2, accessory subunit (POLG2, CN440810, OLIGO_08124), is important during the blastocyst stage for mitochondrial DNA transcription and replication (Lloyd et al. 2009 ). These results are consistent with multiple studies that reported underexpression of genes with transferase activity in placental and embryo samples from abnormal relative to normal pregnancies in human and mouse (Prokopenko et al. 2002; El-Bassiouni et al. 2005; Toledo et al. 2006; Rausell et al. 2007; Obolenskaya et al. 2010) .
Two genes differentially expressed between AI and NT in both meta-analyses and individual-experiment analyses were of particular interest. The consistent pattern of these genes may be related to the lower embryo survival and efficiency of NT relative to AI. One of these genes, a gene similar to calcium/calmodulin-dependent protein kinase II delta (CAMK2D, Hs.610896, OLIGO_04736), was overexpressed in NT versus AI samples. Salilew-Wondim et al. (2010) reported CAMK2D as part of the fingerprint of the bovine pre-transfer endometrium and embryo transcriptome fingerprint. The CAMK2D gene has transferase activity, and thus this finding is consistent with the over-representation of the transferase activity function among the genes differentially expressed between reproductive technologies reported in this study. The other gene was solute carrier family 22 (organic cation transporter) member 1 (SLC22A1, CK772645, OLIGO_12625), which was over-expressed in NT versus AI samples. This gene encodes for membranespanning transporter proteins that show tissue-specific expression patterns in embryos (Verhaagh et al. 1999) and is involved in the functional capacity of the placenta (Rivera et al. 2008) .
The identification of genes that exhibit opposite patterns between AI and NT across developmental stages and tissue sources offers insights into temporal-or spatial-dependent impact of the reproductive technologies on the transcriptome that could translate into reproductive efficiency differences. Eight genes were differentially expressed genes in two individual-experiment analyses but had opposite signs in each experiment (Table 2) . Among them, heart and neural crest derivatives expressed two (HAND2, DV784696, OLIGO_03653): over-expressed in AI versus NT samples in d280X and under-expressed in AI versus NT samples in d7E. Gene HAND2 is crucial to the survival of Table 3 Number of differentially expressed genes between the levels of the conditions: developmental stages (7, 25, and 280 days), tissue sources (extra-embryonic or X and embryonic or E) and reproductive technology (AI and NT)
Factors
Within technology and source Within technology and stage
Equal (=) symbol denotes the condition levels (stages, sources, or technologies) shared by the samples being compared. Different symbol (≠) denotes the condition levels that differ between the samples being compared a Number of differentially expressed genes (P value<1×10 −3 and fold change >1.23) mouse embryos past 10.5 days post-conception (Srivastava et al. 1997) and is involved in the development of cardiovascular structures (Morikawa and Cserjesi 2008) . Our finding suggests potentially different roles of HAND2 across developmental stages and tissue sources and is consistent with the over-representation of transferase activity function among the genes differentially expressed between reproductive technologies found in this study. Gene HAND2 pertains to a helix-loop-helix transcription factor family known to interact with transferase factors, and this interaction is essential for modulating transcriptional activity as well as controlling differentiation (Dai and Cserjesi 2002) . In addition, four of the eight genes had opposite expression sign between d7E and d25E. The polymerase, gamma 2, accessory subunit (POLG2, CN440810, OLIGO_08124), was over-expressed in AI versus NT samples in d7E and under-expressed in AI versus NT samples in d25E. This result is consistent with a report that the expression of POLG2 increases dramatically during the blastocyst stage. This gene has also been involved in mitochondrial DNA replication that, in turn, is important for embryo survival (Facucho-Oliveira et al. 2007 ). The detection of POLG2 is consistent with the overrepresentation of transferase activity among the genes differentially expressed between reproductive technologies reported in this study because POLG2 has nucleotidyl transferase activity.
Comparison of the results from the individual-experiment analyses (Table 1) indicates that a higher number of differentially expressed genes between AI and NT can be detected in embryo compared to extra-embryonic tissue and at earlier compared to later stages of development. These results provide insights into the adjustments of the embryonic and extra-embryonic system associated with reproductive technologies. Specific examples of these genes are given. Cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1, CB170385, OLIGO_08251), was underexpressed in NT versus AI samples in d280X; however, it was not differentially expressed in d25X. Our finding is consistent with reports of the importance of this gene in placental progesterone synthesis (Hu et al. 2004) . Additional sex combs like 1 (ASXL1, DT817577, OLIGO_04004) was under-expressed in NT versus AI samples in d7E but was not differentially expressed in d25E. Mutations in this gene were associated with myelodysplastic syndromes (Gelsi-Boyer et al. 2009 ) that encompass ineffective blood production in the embryo and with reduced vascularization in placental tissues. These phenotypes may be associated with the frequency of large-offspring syndrome in fetuses produced by NT or with failed pregnancies. E1A binding protein p300 (EP300, Hs.517517, OLIGO_05064) was under-expressed in AI compared to NT d25E. This protein is involved in nervous system development, homeostasis, and apoptosis (Bundy et al. 2006; Byun et al. 2009 ). Lastly, neuropeptide gene oxytocin (OXT, M25648, OLIGO_12229) was underexpressed in AI compared to NT d280X samples (P value <0.005). Oxytocin is involved in smooth-muscle contractions during parturition and lactation and in maternal behavior and cardiovascular function (Gimpl and Fahrenholz 2001) . Large amounts of OXT are produced by the corpus luteum in the presence of high levels of prostaglandin (PGF2a), decreasing embryonic survival (Seals et al. 1998) . Prostaglandin increases during times of stress usually encountered through embryos created using assisted reproductive techniques (Schallenberger et al. 1989) . The previous genes are potential reliable markers for embryo survival across technologies based on the findings from our study and literature review of the role of these genes on embryo development.
Among the genes consistently differentially expressed between AI and NT in two experiments, protein phosphatase 1, regulatory subunit 12C (PPP1R12C, BM364003, OLIGO_05509), was over-expressed in NT versus AI in d7E and d25E and was not differentially expressed in either d25X or d280X. Choong et al. (2007) reported that a miRNA targeting PPP1R12C was differentially expressed during hematopoietic differentiation obtained from erythroid cultures from umbilical cord blood. Conversely, two genes were only differentially expressed between AI and NT in extra-embryonic sources (d25X, d280X). The first gene, lymphocyte antigen 6 complex locus G6C (LY6G6C, CV798714, OLIGO_08173), is part of the major histocompatibility complex III and was over-expressed in AI versus NT in both d25X and d280X. This association was confirmed by a report that LY6G6C was upregulated in the cattle endometrium of pregnant versus control cows at 18 days of gestation (Klein et al. 2006) . The second gene, thyroid-hormone-receptorassociated protein 6 (THRAP6 or Trap25 or MED30 mediator complex subunit 30, BC110250, OLIGO_06132), was under-expressed in AI versus NT in both d25X and d280X. This finding is consistent with reports of defects in Trap function affecting nuclear receptor signaling and resulting in severe defects during embryonic development (Rienzo et al. 2010) .
The study-level and sample-level meta-analyses identified genes differentially expressed between AI and NT that were detected on previous reports of the individual experiments. These genes included polo-like kinase 4 (PLK4, CN437097, OLIGO_02307), structural maintenance of chromosomes 4-like-1 (SMC4L1, CV981642, OLIGO_02116), EBNA1 binding protein 2 (EBNA1BP2, BC102356, OLIGO_07973), topoisomerase II binding protein 1 (TOPBP1, CK977601, OLIGO_03810), SMC4L1 (CV981642, OLIGO_02116), and vesicle-associated membrane protein 3 (VAMP3, BC105399, OLIGO_10402) and were reported by Everts et al. (2008) .
The results from all analyses for four genes that have differential expression between AI and NT are summarized in funnel plots (Fig. 2) . These plots confirm the complementary properties of the individual-experiment, studylevel, and sample-level meta-analyses reported by Rodriguez-Zas et al. (2008) and Adams et al. (2008) . Deoxycytidylate deaminase (DCTD or DCMP, CR550800, OLIGO_00155) was detected to be over-expressed in AI relative to NT by the study-level and sample-level metaanalyses, yet it was not detected in any of the four individual-experiment analyses because of insufficient precision (Fig. 2a) . This result is in agreement with accounts that inhibition of DCTD results in the inhibition of growth in chicken embryos (Roth et al., 1963) . Mitochondrial fission regulator 1 (MTFR1, CX948597, OLIGO_06762) exhibited differential expression between AI and NT in two individual-experiment analyses (d280X, d25E) but with different signs (Fig. 2b ). Neither the studylevel nor the sample-level meta-analysis was able to detect differential expression for this gene because of the opposite expression pattern across the individual-experiment analyses. The differential expression found in the d25E experiment is consistent with previous reports of association between this protein, mitochondrial fission, and embryo development (Chan 2006; Monticone et al. 2007 ). Vesicleassociated membrane protein 3 (VAMP3, BC105399, OLIGO_10402) was over-expressed in AI relative to NT in the sample-level meta-analysis (Fig. 2c) . The limited information from the combination of four estimates prevented the detection of differential expression by the study-level meta-analysis. The detection of VAMP3 by the sample-level meta-analysis is supported by studies indicating that this protein is involved in cell migration, an essential process for embryonic development (Luftman et al. 2009 ). Chromosomes 4-like 1 gene (SMC4L1, CV981642, OLIGO_02116) was detected to be under-expressed in AI relative to NT in the study-level meta-analysis (Fig. 2d) . The consideration of heterogeneity of variance among experiments in the study-level meta-analysis allowed this approach to uncover differential expression for this gene. This finding is supported by previous work that detected over-expression of SMC4L1 in human fetal wounds relative to postnatal wounds (Colwell et al. 2008) .
Genes differentially expressed between developmental stages and tissue sources within reproductive technology identified by the second set of meta-analyses
The high number of differentially expressed genes detected among the first four contrasts between developmental stages within reproductive technology and the low number of differentially expressed genes detected in the last two contrasts between tissue sources within reproductive technology from the second set of meta-analysis indicate that developmental stage is associated with more changes in the transcriptome than in the tissue source. This result suggests that embryonic and extra-embryonic tissues may exhibit similar differences in gene expression between reproductive technologies or developmental stages.
The detection of differentially expressed genes between developmental stages or between tissue sources within reproductive technology offer insights into the plasticity of the transcriptome and impact of reproductive technology at particular developmental stages (Table 3) . Among the genes identified as differentially expressed by the second set of meta-analysis, peroxiredoxin 1 (PRDX1, BT021073, OLIGO_07962) and SLC16A1 (BC104598, OLIGO_12806) were over-expressed in 7-day relative to 25-day AI embryos and under-expressed in 7-day relative to 25-day NT embryos. The patterns for PRDX1 and SLC16A1 may be associated with more frequent developmental problems in NT relative to AI embryos. Supporting this hypothesis, Mourot et al. (2006) reported that PRDX1 is involved in antioxidant defenses and developmental competence in bovine embryos. Similarly, Somers et al. (2006) found SLC16A1 to be underexpressed in NT relative to non-NT embryos and suggested that a reduced expression of the gene, specifically during the early blastocyst stage, may affect embryonic viability. These results are consistent with multiple studies that reported changes in genes pertaining to the system development biological process between developmental stages in various mammalian tissues (Ruberte et al. 1993; Cardoso and Lu 2006; Laranjeira and Pachnis 2009) .
Among the genes differentially expressed between 25 and 280 days (Table 3) , major histocompatibility complex class II DQ beta 1 (HLA-DQB1, AJ580584, OLIGO_10954) was under-expressed in 25 days relative to 280 days in both AI and NT extra-embryonic samples. The result for HLA-DQB1 is consistent with reports that this gene is expressed in the trophoblast (outer layer cells of the blastocyst that will form the placenta) of cloned pregnancies after the fifth month of pregnancy (Hill et al. 2002) . Expression of HLA-DQB1 within cattle trophoblast tissue has not been found during the first trimester pregnancies, and this is supported by the lower expression of HLA-DQB1 in early extra-embryonic tissue at 25 days compared to 280 days in both technologies.
In summary, the information from four microarray experiments that profiled cattle gene expression from two reproductive technologies at different developmental stages and tissue source was integrated. The meta-analyses allowed the detection of differentially expressed genes and to gain insights into the embryonic-extra-embryonic transcriptomic system that would have been missed from the individualexperiment analyses. Genes affiliated to system development processes were over-represented among the genes differentially expressed between developmental stages.
Genes with transferase activity function were overrepresented among the genes differentially expressed between reproductive technologies. This finding is consistent with long-standing and abundant reports of differential expression on genes with transferase activity between abnormal and normal pregnancies (Gibbs et al. 1984; Mirlesse et al. 1996) . The ontology categories and genes identified in this study provide candidates for further defining the differences in embryo viability between reproductive technologies and developmental stages.
